Increasing exposure levels cause an abrupt change in the absorption and metabolism of acutely inhaled benzo(a)pyrene in the isolated, ventilated, and perfused lung of the rat.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractThe carcinogenic polycyclic aromatic hydrocarbons (PAHs) are active primarily at the site of entry to the body. Lung cancer following inhalation of PAH-containing aerosols such as tobacco smoke is one likely example. A suggested mechanism for this site preference is a slow passage of the highly lipophilic PAHs through the thicker epithelia of the conducting airways, accompanied by substantial local metabolism in airway epithelium. However, it is likely that the airway epithelium will become saturated with PAHs at surprisingly low exposure levels. The purpose of this research was to quantify the level of saturation for inhaled benzo(a)pyrene (BaP) in the isolated, perfused lung (IPL) of the rat. BaP was coated onto carrier particles of silica 3.5 microm diameter at three different levels. The DustGun aerosol generator was then used to deliver respectively 2.2, 36, and 8400 ng of BaP to the IPL with the carrier particles in less than 1 min. For 77 min after the exposure, single-pass perfusate was collected from the lungs. Lungs were then removed and, with the perfusate, analyzed for BaP and metabolites. Results show that the absorption and metabolism of inhaled BaP in the lungs was highly dose dependent. At low exposure levels absorption of BaP in the mucosa was proportional to the concentration in the air/blood barrier and proceeded with substantial local metabolism. At higher exposure levels the capacity of the epithelium to dissolve and metabolize BaP became saturated, and the absorption rate remained constant until crystalline BaP had dissolved, and the process proceeded with much smaller fractions of BaP metabolites produced in the mucosa. This phenomenon may explain the well-known difficulties of inducing lung cancer in laboratory animals with inhalants containing carcinogenic PAHs, where similar lifespan exposures are used as humans may experience but with much higher dose rates.
CitationToxicol. Sci. 2006, 91 (2):332-340
DescriptionKEYWORDS - CLASSIFICATION: administration & dosage;Administration,Inhalation;Animals;Benzo(a)pyrene;drug effects;Dose-Response Relationship,Drug;Female;Lung;metabolism;mechanisms of carcinogenesis;pharmacokinetics;Perfusion;Rats;Rats,Sprague-Dawley;Research;Silicon Dioxide;Sweden.
- Respiratory epithelial penetration and clearance of particle-borne benzo[a]pyrene.
- Authors: Gerde P, Muggenburg BA, Lundborg M, Tesfaigzi Y, Dahl AR
- Issue date: 2001 Apr
- Benzo[a]pyrene at an environmentally relevant dose is slowly absorbed by, and extensively metabolized in, tracheal epithelium.
- Authors: Gerde P, Muggenburg BA, Thornton-Manning JR, Lewis JL, Pyon KH, Dahl AR
- Issue date: 1997 Sep
- Lung retention and metabolic fate of inhaled benzo(a)pyrene associated with diesel exhaust particles.
- Authors: Sun JD, Wolff RK, Kanapilly GM, McClellan RO
- Issue date: 1984 Mar 30
- Toxicokinetics of inhaled benzo[a]pyrene: plasma and lung bioavailability.
- Authors: Ramesh A, Greenwood M, Inyang F, Hood DB
- Issue date: 2001 Jun
- The rapid alveolar absorption of diesel soot-adsorbed benzo[a]pyrene: bioavailability, metabolism and dosimetry of an inhaled particle-borne carcinogen.
- Authors: Gerde P, Muggenburg BA, Lundborg M, Dahl AR
- Issue date: 2001 May